Skip to main content
Top
Published in: International Urology and Nephrology 2/2018

01-02-2018 | Urology - Original Paper

Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI

Authors: Yulian Mytsyk, Ihor Dutka, Borys Yuriy, Iryna Maksymovych, Martin Caprnda, Katarina Gazdikova, Luis Rodrigo, Peter Kruzliak, Polina Illjuk, Ammad Ahmad Farooqi

Published in: International Urology and Nephrology | Issue 2/2018

Login to get access

Abstract

Introduction

Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and more than 90% of neoplasms arising from the kidney. Uninformative percutaneous kidney biopsies vary from 10 to 23%. As a result, 7.5–33.6% of partial nephrectomies in patients with small renal masses (SRM) are performed on benign renal tumors. The aim of this study was to assess the feasibility of the apparent diffusion coefficient (ADC) of the diffusion-weighted imaging (DWI) of MRI, as RCC imaging biomarker for differentiation of SRM.

Method

Adult patients (n = 158) with 170 SRM were enrolled into this study. The control group were healthy volunteers with normal clinical and radiologic findings (n = 15). All participants underwent MRI with DWI sequence included.

Results

Mean ADC values of solid RCC (1.65 ± 0.38 × 10−3 mm2/s) were lower than healthy renal parenchyma (2.47 ± 0.12 × 10−3 mm2/s, p < 0.05). There was no difference between mean ADC values of ccRCC, pRCC and chRCC (1.82 ± 0.22 × 10−3 vs 1.61 ± 0.07 × 10−3 vs 1.46 ± 0.09 × 10−3 mm2/s, respectively, p = ns). An inverse relationship between mean ADC values and Fuhrman grade of nuclear atypia of solid ccRCCs was observed: grade I—1.92 ± 0.11 × 10−3 mm2/s, grade II—1.84 ± 0.14 × 10−3 mm2/s, grade III—1.79 ± 0.10 × 10−3 mm2/s, grade IV—1.72 ± 0.06 × 10−3 mm2/s. This was significant (p < 0.05) only between tumors of I and IV grades. Significant difference (p < 0.05) between mean ADC values of solid RCCs, benign renal tumors and renal cysts was observed (1.65 ± 0.38 × 10−3 vs 2.23 ± 0.18 × 10−3 vs 3.15 ± 0.51 × 10−3 mm2/s, respectively). In addition, there was a significant difference (p < 0.05) in mean ADC values between benign cysts and cystic RCC (3.36 ± 0.35 × 10−3 vs 2.83 ± 0.21 × 10−3 mm2/s, respectively).

Conclusion

ADC maps with b values of 0 and 800 s/mm2 can be used as an imaging biomarker, to differentiate benign SRM from malignant SRM. Using ADC value threshold of 1.75 × 10−3 mm2/s allows to differentiate solid RCC from solid benign kidney tumors with 91% sensitivity and 89% specificity; ADC value threshold of 2.96 × 10−3 mm2/s distinguishes cystic RCC from benign renal cysts with 90% sensitivity and 88% specificity. However, the possibility of differentiation between ccRCC histologic subtypes and grades, utilizing ADC values, is limited.
Literature
1.
go back to reference Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2016) SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda, MD, USA, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. http://seer.cancer.gov/csr/1975_2013/ Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2016) SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda, MD, USA, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. http://​seer.​cancer.​gov/​csr/​1975_​2013/​
2.
go back to reference Gill IS, Aron M, Gervais DA, Jewett MA (2010) Clinical practice: small renal mass. N Engl J Med 362:624–634CrossRefPubMed Gill IS, Aron M, Gervais DA, Jewett MA (2010) Clinical practice: small renal mass. N Engl J Med 362:624–634CrossRefPubMed
3.
go back to reference Phé V, Yates DR, Renard-Penna R, Cussenot O, Rouprêt M (2012) Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses? BJU Int 109:867–872CrossRefPubMed Phé V, Yates DR, Renard-Penna R, Cussenot O, Rouprêt M (2012) Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses? BJU Int 109:867–872CrossRefPubMed
4.
go back to reference Jeon HG, Seo SI, Jeong BC, Jeon SS, Lee HM, Choi HY, Song C, Hong JH, Kim CS, Ahn H, Jeong IG (2016) Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol 195:568–573CrossRefPubMed Jeon HG, Seo SI, Jeong BC, Jeon SS, Lee HM, Choi HY, Song C, Hong JH, Kim CS, Ahn H, Jeong IG (2016) Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol 195:568–573CrossRefPubMed
5.
go back to reference Volpe A, Terrone C, Scarpa RM (2009) The current role of percutaneous needle biopsies of renal tumours. Arch Ital Urol Androl 81:107–112PubMed Volpe A, Terrone C, Scarpa RM (2009) The current role of percutaneous needle biopsies of renal tumours. Arch Ital Urol Androl 81:107–112PubMed
6.
go back to reference Menogue SR, O’Brien BA, Brown AL, Cohen RJ (2013) Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int 111:E146–E151CrossRefPubMed Menogue SR, O’Brien BA, Brown AL, Cohen RJ (2013) Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int 111:E146–E151CrossRefPubMed
7.
go back to reference Michael B, Prince J, Bultman E (2015) Predictors of non-diagnostic renal mass biopsy. J Urol 4:532–533 Michael B, Prince J, Bultman E (2015) Predictors of non-diagnostic renal mass biopsy. J Urol 4:532–533
8.
go back to reference Link RE, Bhayani SB, Allaf ME, Varkarakis I, Inagaki T, Rogers C, Su LM, Jarrett TW, Kavoussi LR (2005) Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol 173:1690–1694CrossRefPubMed Link RE, Bhayani SB, Allaf ME, Varkarakis I, Inagaki T, Rogers C, Su LM, Jarrett TW, Kavoussi LR (2005) Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol 173:1690–1694CrossRefPubMed
9.
go back to reference Fananapazir G, Lamba R, Lewis B, Corwin MT, Naderi S, Troppmann C (2015) Utility of MRI in the characterization of indeterminate small renal lesions previously seen on screening CT scans of potential renal donor patients. AJR Am J Roentgenol 205:325–330CrossRefPubMed Fananapazir G, Lamba R, Lewis B, Corwin MT, Naderi S, Troppmann C (2015) Utility of MRI in the characterization of indeterminate small renal lesions previously seen on screening CT scans of potential renal donor patients. AJR Am J Roentgenol 205:325–330CrossRefPubMed
10.
go back to reference Baliyan V, Das CJ, Sharma S, Gupta AK (2014) Diffusion-weighted imaging in urinary tract lesions. Clin Radiol 69:773–782CrossRefPubMed Baliyan V, Das CJ, Sharma S, Gupta AK (2014) Diffusion-weighted imaging in urinary tract lesions. Clin Radiol 69:773–782CrossRefPubMed
11.
go back to reference Doğanay S, Kocakoç E, Ciçekçi M, Ağlamiş S, Akpolat N, Orhan I (2011) Ability and utility of diffusion-weighted MRI with different B values in the evaluation of benign and malignant renal lesions. Clin Radiol 66:420–425CrossRefPubMed Doğanay S, Kocakoç E, Ciçekçi M, Ağlamiş S, Akpolat N, Orhan I (2011) Ability and utility of diffusion-weighted MRI with different B values in the evaluation of benign and malignant renal lesions. Clin Radiol 66:420–425CrossRefPubMed
12.
go back to reference Agnello F, Roy C, Bazille G, Galia M, Midiri M, Charles T, Lang H (2013) Small solid renal masses: characterization by diffusion-weighted MRI at 3 T. Clin Radiol 68:301–308CrossRef Agnello F, Roy C, Bazille G, Galia M, Midiri M, Charles T, Lang H (2013) Small solid renal masses: characterization by diffusion-weighted MRI at 3 T. Clin Radiol 68:301–308CrossRef
13.
go back to reference Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB (2007) High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Br J Cancer 96:1888–1895CrossRefPubMedPubMedCentral Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB (2007) High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Br J Cancer 96:1888–1895CrossRefPubMedPubMedCentral
14.
go back to reference Kuthi L, Jenei A, Hajdu A, Németh I, Varga Z, Bajory Z, Pajor L, Iványi B (2017) Prognostic factors for renal cell carcinoma subtypes diagnosed according to the 2016 WHO renal tumor classification: a study involving 928 patients. Pathol Oncol Res 23(689):698 Kuthi L, Jenei A, Hajdu A, Németh I, Varga Z, Bajory Z, Pajor L, Iványi B (2017) Prognostic factors for renal cell carcinoma subtypes diagnosed according to the 2016 WHO renal tumor classification: a study involving 928 patients. Pathol Oncol Res 23(689):698
15.
go back to reference Mytsyk Y, Dutka I, Borys Y, Komnatska I, Shatynska-Mytsyk I, Farooqi AA, Gazdikova K, Caprnda M, Rodrigo L, Kruzliak P (2017) Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade. Int Urol Nephrol 49:215–224CrossRefPubMed Mytsyk Y, Dutka I, Borys Y, Komnatska I, Shatynska-Mytsyk I, Farooqi AA, Gazdikova K, Caprnda M, Rodrigo L, Kruzliak P (2017) Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade. Int Urol Nephrol 49:215–224CrossRefPubMed
16.
go back to reference Ponhold L, Javor D, Heinz-Peer G, Sevcenco S, Hofstetter M, Baltzer PA (2016) Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses. Acta Radiol 57:1014–1020CrossRefPubMed Ponhold L, Javor D, Heinz-Peer G, Sevcenco S, Hofstetter M, Baltzer PA (2016) Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses. Acta Radiol 57:1014–1020CrossRefPubMed
Metadata
Title
Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI
Authors
Yulian Mytsyk
Ihor Dutka
Borys Yuriy
Iryna Maksymovych
Martin Caprnda
Katarina Gazdikova
Luis Rodrigo
Peter Kruzliak
Polina Illjuk
Ammad Ahmad Farooqi
Publication date
01-02-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1761-1

Other articles of this Issue 2/2018

International Urology and Nephrology 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.